+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acadia Pharmaceuticals Inc - logo

Acadia Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease, Phase II trial for the treatment of schizophrenia and Phase II study for the treatment of Alzheimer's disease. The company was founded in 1993 and is headquartered in San Diego, California.

Schizophrenia Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Schizophrenia Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
Schizophrenia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Schizophrenia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Schizophrenia Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Schizophrenia Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 397 Pages
  • Global
From
Schizophrenia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Schizophrenia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • October 2022
  • 113 Pages
  • Global
From
Blood Brain Barrier Market, 3rd Edition - Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Route of Administration, Target Disease Indication, Therapeutic Area and Key Geographical Regions - Product Thumbnail Image

Blood Brain Barrier Market, 3rd Edition - Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Route of Administration, Target Disease Indication, Therapeutic Area and Key Geographical Regions

  • Report
  • September 2024
  • 375 Pages
  • Global
From
Neuroregeneration Therapy Market - Global Strategic Business Report - Product Thumbnail Image

Neuroregeneration Therapy Market - Global Strategic Business Report

  • Report
  • February 2026
  • 480 Pages
  • Global
From
Schizoaffective Drug Market by Therapeutic Class, Treatment, by End-Users, and By Region - Product Thumbnail Image

Schizoaffective Drug Market by Therapeutic Class, Treatment, by End-Users, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Schizophrenia- Pipeline Insight, 2025 - Product Thumbnail Image

Schizophrenia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Treatment Resistant Depression Market - Global Strategic Business Report - Product Thumbnail Image

Treatment Resistant Depression Market - Global Strategic Business Report

  • Report
  • February 2026
  • 277 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 380 Pages
  • Global
From
Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 295 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2019-2025 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2019-2025

  • Report
  • October 2025
  • 500 Pages
  • Global
From
Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2025 - Product Thumbnail Image

Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Treatment Resistant Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Treatment Resistant Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 506 Pages
  • Global
From
Asperger Syndrome - Global Strategic Business Report - Product Thumbnail Image

Asperger Syndrome - Global Strategic Business Report

  • Report
  • February 2026
  • 204 Pages
  • Global
From
Delirium Market - Global Strategic Business Report - Product Thumbnail Image

Delirium Market - Global Strategic Business Report

  • Report
  • February 2026
  • 281 Pages
  • Global
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 382 Pages
  • Global
From
Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • September 2021
  • 325 Pages
  • Global
From
Musculoskeletal Pain - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Musculoskeletal Pain - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Loading Indicator